共 49 条
- [31] Clindamycin phosphate 1.2%/benzoyl peroxide 3% fixed-dose combination gel versus topical combination therapy of adapalene 0.1% gel and clindamycin phosphate 1.2% gel in the treatment of acne vulgaris in Japanese patients: A multicenter, randomized, investigator-blind, parallel-group studyJOURNAL OF DERMATOLOGY, 2018, 45 (08): : 951 - 962Hayashi, NobukazuKurokawa, IchiroSiakpere, ObukohwoEndo, AkiraHatanaka, ToshikiYamada, MasahiroKawashima, Makoto
- [32] Clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel for moderate-to-severe acne: Efficacy and safety results from two randomized phase 3 trialsJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (05) : 927 - 935Gold, Linda SteinLain, EdwardDel Rosso, James Q.Gold, MichaelDraelos, Zoe D.Eichenfield, Lawrence F.Sadick, NeilWerschler, William P.Gooderham, Melinda J.Lupo, Mary
- [33] A COST-EFFECTIVENESS ANALYSIS OF A TRIPLE-AGENT TOPICAL FIXED-DOSE COMBINATION OF 1.2% CLINDAMYCIN PHOSPHATE, 0.15% ADAPALENE, AND 3.1% BENZOYL PEROXIDE GEL FOR THE TREATMENT OF MODERATE-TO-SEVERE ACNE VULGARIS IN THE UNITED STATESVALUE IN HEALTH, 2024, 27 (06) : S131 - S131Dey, D.Harper, J.Paul, Choudhury S.Dutta, S.Thomas, A.Bhattacharyya, S.Padula, W.Lin, T.Olujohungbe, O.Jospeh, G.Dashputre, A.
- [34] Efficacy and Safety of a Ceramide Containing Moisturizer Followed by Fixed-dose Clindamycin Phosphate 1.2%/Benzoyl Peroxide 2.5% Gel in the Morning in Combination With a Ceramide Containing Moisturizer Followed by Tretinoin 0.05% Gel in the Evening for the Treatment of Facial Acne VulgarisJOURNAL OF DRUGS IN DERMATOLOGY, 2012, 11 (06) : 748 - 752Zeichner, Joshua A.Patel, Rita V.Haddican, MadelaineWong, Vicky
- [35] Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed dose combination gel for the treatment of acne vulgaris: A multicenter, double-blind, parallel group, vehicle controlled studyJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (04) : AB10 - AB10Eichenfield, LawrenceAlio, Alessandra
- [36] Efficacy and safety of a fixed-dose clindamycin 1.2%, benzoyl peroxide 3.1%, and adapalene 0.15% gel for moderate-to-severe acne: Randomized phase 2 and phase 3 studies of the first triple-combination drugJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB50 - AB50Gold, Linda SteinKircik, Leon H.Tanghetti, Emil A.
- [37] High Efficiency and good Therapeutic Adherence with the Fixed Dose Combination of Adapalene 0.1%/Benzoyl Peroxide 2.5% in Adolescents and young Adults with moderate AcneJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 166 - 166Gollnick, H.Rechberg, V. C.Fraenken, J.Kors, C.Simon, M.Jaeckel, A.
- [38] Dermal Irritation, Sensitization, and Safety of Fixed-Dose Triple-Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.1%/Adapalene 0.15% Gel in Healthy ParticipantsJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB33 - AB33Draelos, ZoeTanghetti, EmilGold, Linda SteinKircik, LeonBhatia, NealZeichner, JoshuaSugarman, Jeffrey
- [39] Interim analysis of long-term non-Interventional study with an Adapalene 0.1%/Benzoyl peroxide 2.5% fixed combination in patients with moderate to severe acneJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2014, 12 : 15 - 15Gollnick, H.Rechberg, V. C.Jaeckel, A.